Bruker Corp

Bruker Corp

BRKR

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.57B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bruker CorpBruker Corp-262.90.32%0%2.30.9
$54.60

Target Price by Analysts

8.5% upsideBruker Target Price DetailsTarget Price
$9.68

Current Fair Value

80.8% downside

Overvalued by 80.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.57 Billion
Enterprise Value$11.58 Billion
Dividend Yield$0.20 (0.32%)
Earnings per Share$-0.15
Beta1.29
Outstanding Shares152,200,000

Return

Return on Equity-0.47%ROE
Return on Assets-0.19%
Return on Invested Capital0.81%

Valuation & Multiples

P/E Ratio-262.93P/E Ratio
PEG1524.99PEG
Price to Sales2.29Price to Sales
Price to Book Ratio3.14Price to Book Ratio
Enterprise Value to Revenue3.35
Enterprise Value to EBIT300.87
Enterprise Value to Net Income-999
Total Debt to Enterprise0.19
Debt to Equity0.87Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectation
Revenue Estimate
$853.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.55
Average shareholder expectation
Revenue Estimate
$878.32 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 77.76%
Total Calls200 99.91%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.24% 87.94%
Total Invested$174.40M 96.47%
Investors Holding119 231.00%

ESG Score

No data

About Bruker Corp

6,000 employees
CEO: Frank Laukien

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...